
Panelists challenge the belief that testosterone fuels prostate cancer, explain PSA on therapy and TRAVERSE BPH data, and weigh Schedule III status.
A free, centralized online database with the results of all controlled clinical drug trials (mainly phase III and IV studies) will be available next month to the public at www.clinicalstudyresults.org.





